By reducing the level at which traces of blood in a FIT test trigger further investigation – from 120 micrograms of blood per gram of poo down to 80 – the NHS will offer 35% more screening ...

Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

Review highlights gut microbiota dysbiosis as an emerging colorectal cancer risk factor, with microbial signatures, including Fusobacterium nucleatum, showing promise as non-invasive biomarkers to ...

Colorectal cancer screening remains a cornerstone of preventive medicine, with strategies evolving to reduce both incidence and mortality worldwide. Current screening programmes utilise a range of ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

Colorectal cancer incidence and mortality have increased among younger adults in recent years, with the most significant increase seen in those ages 40 to 49. Starting FIT screening early was tied to ...

Historically, the gold standard for diagnosing colorectal cancer has been a colonoscopy. During the procedure, a thin tube with a camera is inserted into the rectum, which lets the doctor examine the ...

Mailing fecal immunochemical tests (FIT) directly to patients significantly increased colorectal cancer screening rates compared to active choice approaches. The study involved 20,509 adults aged 45 ...